PReS-FINAL-2349: Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies by unknown
POSTER PRESENTATION Open Access
PReS-FINAL-2349: Spectrum of thrombotic and
non-thrombotic manifestations in 159 children
with positive antiphospholipid antibodies
M Rozic1*, A Trampus-Bakija2, Z Rener-Primec2, L Kitanovski2, T Kveder3, T Avcin2
From 20th Pediatric Rheumatology European Society (PReS) Congress
Ljubljana, Slovenia. 25-29 September 2013
Introduction
Antiphospholipid antibodies (aPL) play the central
pathogenic role in antiphospholipid syndrome (APS)
characterized by arterial and venous thrombosis, recurrent
fetal loss and persistent circulating aPL. The diagnostic
criteria of definite APS are not entirely applicable in pedia-
tric population. An international multicentric project
named Ped-APS registry included 121 patients with APS
onset before 18th birthday. Almost half of them (49.5%)
had an associated autoimmune disease. In this study a
large percentage of children with aPL-related thrombotic
event had at the time of the initial thrombotic event asso-
ciated nonthrombotic clinical manifestations including:
hematological manifestations (38%), dermatological
manifestations (18%) and nonthrombotic neurological
manifestations (16%).
Objectives
To evaluate the spectrum of thrombotic and non-throm-
botic clinical manifestations associated with aPL, namely
anticardiolipin antibodies (aCL), anti-ß2-glycoprotein I
antibodies (anti-ß2GPI) and lupus anticoagulant (LA),
among children with positive laboratory results when
tested for the presence of aPL.
Methods
Pediatric patients in a tertiary care hospital were accord-
ing to the clinical judgment of the treating physician
tested for the presence of aPL and the laboratory results
were saved in a computer database. In this single-center
bidirectional study we included 159 consecutive patients
from the database that tested medium or highly positive
for aCL and/or positive for anti-ß2GPI and/or positive
for LA at least once in the period from January 1997 to
July 2012. Clinical manifestations of these patients were
then evaluated, specifically thrombosis, nonthrombotic
neurological and hematological manifestations, skin dis-
orders and cardiac valve disease.
Results
Of all 159 patients (61 boys and 98 girls, mean age at
the occurrence of symptoms was 11.4 years, range 1 to
18 years of age) 55 had an underlying systemic disease
(Systemic lupus erythematosus 31, Juvenile idiopathic
arthritis 19, Scleroderma 2, Primary Raynaud’s syndrome
2 and Sarcoidosis 1) and 8 had other autoimmune dis-
ease. Sixty-six out of 159 (42%) patients presented with
one aPL-related clinical manifestation, 18 (11%) with
two and 5 (3%) patients presented with three or more
aPL related clinical manifestations. Of the aPL related
clinical manifestations thromboses occurred in 25
patients (venous 16, arterial thrombosis 9, recurrent
thrombosis 2), nonthrombotic neurological disorders
were present in 25 patients (seizures 11, migraine 7,
chorea 2, other 5), hematological disorders in 48
(thrombocytopenia 24, autoimmune hemolytic anemia
10, leucopenia 9, Evans syndrome 5), skin disorders in
19 (Raynaud’s phenomenon 11, livedo reticularis 8) and
a cardiac valve disease in 5.
Conclusion
In an unselected group of children with positive aPL non-
thrombotic clinical manifestations were more frequent
than thrombotic events. The most common clinical man-
ifestations associated with aPL in children are thrombo-
cytopenia, followed by venous thrombosis, seizures and
Raynaud’s phenomenon.
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